Covered recipient · General Payments record
CHRISTINEJOY BACALA DOLIENTE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$858.24
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $858.24 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $246.83 | 2 |
| EISAI INC. | $176.43 | 2 |
| Amgen Inc. | $161.21 | 3 |
| Lilly USA, LLC | $103.12 | 1 |
| Genentech USA, Inc. | $44.30 | 2 |
| ABBVIE INC. | $34.01 | 1 |
| Lundbeck LLC | $31.76 | 1 |
| Grifols USA, LLC | $25.04 | 1 |
| Alnylam Pharmaceuticals Inc. | $20.48 | 1 |
| Octapharma USA, Inc. | $15.06 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $858.24 | 15 |
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.01 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107032287 | CMS |
| Alnylam Pharmaceuticals Inc. | $20.48 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125848558 | CMS |
| Amgen Inc. | $28.92 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115581192 | CMS |
| Amgen Inc. | $121.84 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115581188 | CMS |
| Amgen Inc. | $10.45 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115581181 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.99 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104462536 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.84 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104236455 | CMS |
| Eisai Inc. | $75.05 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110798025 | CMS |
| Eisai Inc. | $101.38 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110798027 | CMS |
| Genentech USA, Inc. | $20.14 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133151213 | CMS |
| Genentech USA, Inc. | $24.16 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133151210 | CMS |
| Grifols USA, LLC | $25.04 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124744522 | CMS |
| Lilly USA, LLC | $103.12 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135588493 | CMS |
| Lundbeck LLC | $31.76 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146014883 | CMS |
| Octapharma USA, Inc. | $15.06 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142321738 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.